In vivo genome editing using a high-efficiency TALEN system
- PMID: 23000899
- PMCID: PMC3491146
- DOI: 10.1038/nature11537
In vivo genome editing using a high-efficiency TALEN system
Abstract
The zebrafish (Danio rerio) is increasingly being used to study basic vertebrate biology and human disease with a rich array of in vivo genetic and molecular tools. However, the inability to readily modify the genome in a targeted fashion has been a bottleneck in the field. Here we show that improvements in artificial transcription activator-like effector nucleases (TALENs) provide a powerful new approach for targeted zebrafish genome editing and functional genomic applications. Using the GoldyTALEN modified scaffold and zebrafish delivery system, we show that this enhanced TALEN toolkit has a high efficiency in inducing locus-specific DNA breaks in somatic and germline tissues. At some loci, this efficacy approaches 100%, including biallelic conversion in somatic tissues that mimics phenotypes seen using morpholino-based targeted gene knockdowns. With this updated TALEN system, we successfully used single-stranded DNA oligonucleotides to precisely modify sequences at predefined locations in the zebrafish genome through homology-directed repair, including the introduction of a custom-designed EcoRV site and a modified loxP (mloxP) sequence into somatic tissue in vivo. We further show successful germline transmission of both EcoRV and mloxP engineered chromosomes. This combined approach offers the potential to model genetic variation as well as to generate targeted conditional alleles.
Conflict of interest statement
SCF, JJE, KJC and DFV hold shares in Recombinetics, Inc., a company that utilizes TALENs for genome modification in large animals. DFV is a listed inventor on a patent application titled “TAL effector-mediated DNA modification” that is co-owned by Iowa State Univ. and the Univ. of Minnesota, and has been licensed to Cellectis, a European biotechnology company.
Figures





References
-
- Huang P, et al. Heritable gene targeting in zebrafish using customized TALENs. Nat Biotechnol. 2011;29:699–700. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- GM088424/GM/NIGMS NIH HHS/United States
- GM63904/GM/NIGMS NIH HHS/United States
- R41HL108440/HL/NHLBI NIH HHS/United States
- P30DK084567/DK/NIDDK NIH HHS/United States
- R01 GM063904/GM/NIGMS NIH HHS/United States
- R56 GM063904/GM/NIGMS NIH HHS/United States
- R41 HL108440/HL/NHLBI NIH HHS/United States
- R21 DA032194/DA/NIDA NIH HHS/United States
- R01 GM088424/GM/NIGMS NIH HHS/United States
- F30 DK083219/DK/NIDDK NIH HHS/United States
- DK083219/DK/NIDDK NIH HHS/United States
- P30 DK084567/DK/NIDDK NIH HHS/United States
- DA032194/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials